Page last updated: 2024-09-02

thromboxanes and Cryptogenic Fibrosing Alveolitis

thromboxanes has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Banovich, NE; Blackwell, TS; Camarata, JE; Carrier, EJ; Chen, J; Chen, X; Freeman, ML; Gokey, JJ; Gulleman, P; Gutor, S; Han, W; Kropski, JA; Polosukhin, VV; Rathinasabapathy, A; Sabusap, C; Sherrill, TP; Suzuki, T; Tada, Y; Tanjore, H; West, JD; Winters, NI; Young, LR	1

Other Studies

1 other study(ies) available for thromboxanes and Cryptogenic Fibrosing Alveolitis

Article	Year
Thromboxane-Prostanoid Receptor Signaling Drives Persistent Fibroblast Activation in Pulmonary Fibrosis. American journal of respiratory and critical care medicine, 2022, 09-01, Volume: 206, Issue:5 Topics: Animals; Bleomycin; F2-Isoprostanes; Fibroblasts; Humans; Idiopathic Pulmonary Fibrosis; Lung; Mice; Mice, Inbred C57BL; Prostaglandins; Receptors, Thromboxane; Thromboxanes; Transforming Growth Factor beta	2022

Article

Year

Thromboxane-Prostanoid Receptor Signaling Drives Persistent Fibroblast Activation in Pulmonary Fibrosis.

American journal of respiratory and critical care medicine, 2022, 09-01, Volume: 206, Issue:5

Topics: Animals; Bleomycin; F2-Isoprostanes; Fibroblasts; Humans; Idiopathic Pulmonary Fibrosis; Lung; Mice; Mice, Inbred C57BL; Prostaglandins; Receptors, Thromboxane; Thromboxanes; Transforming Growth Factor beta

2022